Physical and chemical compatibility of intravenous metronidazole infusion with physiological solutions: UV-Visible Spectroscopy study
- Articles
- Submited: October 30, 2018
-
Published: October 30, 2018
Abstract
Background and Objectives: The instructions of the manufacturer showed that metronidazole infusion solution (5mg/mL) is incompatible with few drugs. This study aimed to determine the physical and chemical compatibilities of metronidazole infusion with commonly used intravenously administered physiological solutions.
Methods: Metronidazole injection in a commercially available concentration of 5mg/mL was mixed with 0.9% sodium chloride, 5% glucose saline or Ringer's solution in the infused bottle or during simulated Y-site injection. metronidazole was examined physically by visual inspection and chemically by ultraviolet-visible spectrophotometer analysis. Adsorption of metronidazole to intravenous administration sets without inline filters was also studied. Furthermore, the compatibility of metronidazole with some drugs related to beta-lactams was studied. Physical incompatibility was determined by visual inspection against a blackand- white background, and chemical incompatibility was measured by a stability-indicating UV-visible spectrophotometer assay for metronidazole.
Results: The absorbance magnitude (O.D.) recorded by UV-visible spectrophotometer showed differences in respect to the infused solutions as well as to the admixed physiological solutions. Moreover, metronidazole is incompatible with Co-amoxicillin and clavulanic acid, and cefepime. .
Conclusions: It is concluded that metronidazole infusion should be separately infused, not admixed with physiological solutions and avoided its combination with beta lactams.
Metrics
References
- Wang FM, Qian XD, Xu H, Yu HY. Efficacy of 5-nitroimidazole derivatives in treatment of bacterial vaginosis. Zhonghua Yi Xue Za Zhi 2008; 88(31) :2201- 3.
- Shemer H, Kunukcu YK, Linden KG .Degradation of the pharmaceutical metronidazole via UV, Fenton and photo-Fenton processes. Chemosphere 2006 ; 63(2):269-76.
- Deepika M, Jain A, Maheshwari RK, Patidar V. Simultaneous spectrophotometric estimation of metronidazole and norfloxacin in combined tablet formulations using hydrotrophy. Asian J Pharm 2008; 1: 357-61.
- Bell RG, Lipford LC, Massanari MJ, Riley CM. Stability of intravenous admixtures of aztreonam and cefoxitin, gentamicin, metronisazole, or tobramycin. Am J Hosp Pharm 1986; 43 (6): 1444-53.
- Jim LK. Physical and chemical compatibility of intravenous ciprofloxacin with other drugs.. The Annals of Pharmacotherapy 1993; 27(6): 704-7
- Canann D, Tyler LS, Barker B, Condie C. Visual compatibility of i.v. medications routinely used in bone marrow transplant recipients. Am J Health Syst Pharm. 2009;66 (8):727-29.
- Thakur AB, Abdelnasser M, Serajuddin AT, Wadke DA. Interaction of metronidazole with antibiotics containing the 2-aminothiazole moiety. Pharm Res 1991;8 (11):1424-29.
- Psathas PA, Kuzmission A, Ikeda K, Yasuo S. Stability of doripenem in vitro in representative infusion solutions and infusion bags. Clin Ther 2008; 30(11):2075-87.
- Elmore RL, Contois ME, Kelly J, Noe A, Poirier A. Stability and compatibility of admixtures of intravenous ciprofloxacin and selected drugs. Clin Ther 1996; 18(2):246-55.
- Trissel LA, Martinez JF. Compatibility of aztreonam with selected drugs during simulated Y-site administration. Am J Health Syst Pharm 1995; 52 (10):1086-90.
- Guo P, Li X, Wang J, You A. Study on the compatibility of cefotaxime with tinidazole in glucose injection. J Pharm Biomed Anal 2007;43(5):1849-1853.
- Chadha R, Jain DV, Kumar A. Quantitative analysis of in vitro compatibility of binary and ternary mixtures of nitroimidazole and macrolides in combination with omeprazole using a calorimetric technique. Pharmazie. 2007; 62(5):327-336.
- Nakai Y, Tokuyama E, Yoshida M, Uchida T. Incompatibility of ceftriaxone sodium with calcium-containing products. Yakugaku Zasshi. 2009;129(11):1385-92.
- Grenet I and Hazebroucq G. Physicochemical incompatibility of injectable drugs: practical considerations. Therapie 1995; 50(3):191-5.